Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

BACKGROUND: Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. OBJECTIVES: We aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yuting, Wang, Yuyan, Wu, Yangxun, Zhang, Shizhao, Liu, Haiping, Yin, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022318/
https://www.ncbi.nlm.nih.gov/pubmed/35448998
http://dx.doi.org/10.1186/s12959-022-00380-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022318/
https://www.ncbi.nlm.nih.gov/pubmed/35448998
http://dx.doi.org/10.1186/s12959-022-00380-4

Ejemplares similares